Abstract. Tumor hypoxia is an important factor in assessment of both cancer progression and cancer treatment efficacy. This has driven a substantial effort toward development of imaging modalities that can directly measure oxygen distribution and therefore hypoxia in tissue. Although several approaches to measure hypoxia exist, direct measurement of tissue oxygen through an imaging approach is still an unmet need. To address this, we present a new approach based on in vivo application of photoacoustic lifetime imaging (PALI) to map the distribution of oxygen partial pressure (pO 2 ) in tissue. This method utilizes methylene blue, a dye widely used in clinical applications, as an oxygen-sensitive imaging agent. PALI measurement of oxygen relies upon pO 2 -dependent excitation lifetime of the dye. A multimodal imaging system was designed and built to achieve ultrasound (US), photoacoustic, and PALI imaging within the same system. Nude mice bearing LNCaP xenograft hindlimb tumors were used as the target tissue. Hypoxic regions were identified within the tumor in a combined US/PALI image. Finally, the statistical distributions of pO 2 in tumor, normal, and control tissues were compared with measurements by a needle-mounted oxygen probe. A statistically significant drop in mean pO 2 was consistently detected by both methods in tumors. © 2013 Society of Photo-Optical Instrumentation Engineers (SPIE)
Introduction
Regions of hypoxia are commonly found in solid tumors. Hypoxia is caused by abnormally low oxygen transport 1 and an imbalance in the supply and consumption of oxygen. 2 Furthermore, tumor hypoxia is strongly linked to a low treatment efficacy in chemotherapy and radiotherapy for several types of human tumors. 3, 4 Hypoxia is also correlated with aggressive tumor phenotype and poor prognosis. 5 Some studies suggest that tumor hypoxia does not depend on tumor size, grade, or extent of necrosis. 6 It has also been shown that tumor oxygenation is not correlated with oxygen saturation of hemoglobin in blood (sO 2 ). 7 Monitoring oxygen partial pressure (pO 2 ) in tumors has profound implications for the planning of effective therapeutic strategies 8, 9 and for assessing methods of modulating tissue oxygen to enhance the efficacy of cancer treatments.
The chemical and physical properties of oxygen enable a wide variety of methods for measuring pO 2 in vivo by both local and regional methods. Clinically, the gold standard is based on the local computerized polarographic needle electrode method. 10 However, these systems are invasive and not capable of mapping (imaging) the oxygen content in tissue. Characterizing the heterogeneity of oxygen distribution over the region of interest is valuable in investigating the underlying pathophysiology as well as for making clinical treatments more effective. 11 This has led to the development of oxygen content imaging methods that can be categorized into three groups: optical, nuclear, and magnetic resonance based. While all these methods provide information about oxygen, each of them has significant limitations. Optical methods including near-infrared spectroscopy 12 and phosphorescence imaging 13 suffer from low penetration depth due to the strong optical scattering in tissue. Nuclear methods use various hypoxia-related probes for positron emission tomography 14 and single-photon emission computed tomography. 15 These radiolabeled compounds indicate activity of cell metabolism, which is not directly related to oxygen content in tissue. Moreover, interpreting the images for identification of hypoxic regions is highly susceptible to time delay between injection of contrast agent and image acquisition. 16 Magnetic resonance based methods include blood oxygen level-dependent magnetic resonance imaging (BOLD-MRI) (Ref. 17) , 19 F MRI (Ref. 18) , electron paramagnetic resonance imaging, 19 and proton-electron double resonance imaging. 20 BOLD-MRI assesses the hemoglobin oxygen saturation and thus can only serve as an indirect measure of tissue oxygenation. Moreover, all MRI methods have a long scanning time and therefore cannot generate real-time images. Other disadvantages include their high cost and incompatibility with implants and pacemakers. Real-time oxygen imaging is particularly beneficial in photodynamic therapy (PDT) where tissue oxygenation changes significantly during the course of treatment and can serve as a critical factor for understanding the posttreatment metabolic pathway of the tumor. 21 Because of the aforementioned inherent limitations in optical, nuclear, and MRI-based methods, these modalities are not commonly implemented in a clinical setting. This indicates a strong clinical need for a new oxygen imaging modality.
In previous work, we have demonstrated the capability of the photoacoustic lifetime imaging (PALI) technique for measuring pO 2 in a phantom. 22 Here, we report our first study in extending this method to image pO 2 distribution in vivo. PALI has several distinctive features that make it a promising alternative to current clinical pO 2 imaging methods. It relies on local measurement of triplet state lifetime of a chromophore. The lifetime is highly dependent on pO 2 for chromophores having a sufficiently stable triplet state. This contrast mechanism is similar to those of pO 2 imaging methods based on phosphorescence lifetime. 23 The readout penetration depth and resolution, however, are greatly improved in PALI because the excitation lifetime is measured by photoacoustic imaging (PAI), a technique that circumvents the difficulty posed by strong optical scattering in tissue. Specifically, PAI relies on detection and imaging of acoustic signals generated by light absorption of short laser pulses. Its resolution is determined by the ultrasound (US) transducer that is used for photoacoustic (PA) signal detection and therefore resembles that of US imaging. 24, 25 Penetration depth of PAI depends on diffused light penetration in tissue and can reach up to 5 cm. 26, 27 PALI utilizes two pulsed laser sources, one for exciting the chromophore and the other for PA probing of the excited state. The first laser pulse pumps the dye to an excited state. The dynamics of relaxation back to the ground state results in transient optical absorption. This transience can be probed by a second pulsed laser that generates PA waves. The amplitudes of these waves depend linearly on optical absorption in the sample. Because the absorption is time dependent, the amplitudes of the waves change with the time delay between the two pulses. Therefore, by altering this time delay, the decay of the excited state population can be measured and the excited state lifetime can be extracted. The PA signals are detected and then processed to reconstruct a PA image at each pump-probe time delay. The sequence of images is then used to track the decay profile of the excited state independently at each pixel position in the field of view. PALI thus provides an image showing the distribution of the excited state lifetime.
Combining PALI with tissue staining by oxygen-sensitive dye yields a method for tissue oxygen imaging. The oxygen sensitivity of these dyes is based on dynamic quenching of the excited state by collisions with oxygen molecules. High oxygen sensitivity requires that the rate of collisions be higher than the relaxation rate of the excited state. For this reason, long-lifetime dyes are preferred for oxygen sensing. Particularly, useful dyes exhibit efficient intersystem crossing to a metastable triplet state. In this case, the lifetime is typically in the microsecond or even millisecond range.
In this work, we chose to use methylene blue (MB) as an oxygen-sensitive dye. MB is a water-soluble dye that is widely used in clinical diagnostic and therapeutic applications. [28] [29] [30] This is due to its low cytotoxicity and efficient clearance from the body via bile, feces, and urine. 31, 32 In addition, the lifetime of MB is an intrinsic property and does not depend on its concentration (79.5 μs in oxygen-depleted solution 33 ). MB is relatively stable in stained tissue for up to several hours. After this period, transport via blood circulation and lymphatic clearing takes place as well as the reduction of MB to its nonabsorbing leuco form. Because image acquisition time is typically <3 min, this time window of relatively stable dye concentration in the target tissue is long enough to warrant its application in PALI oxygen imaging.
In vivo application of the lifetime-based PA technique has previously been reported by Ray et al. 34 They used G2, a dendrimer-based oxygen-sensitive dye, 35 to measure pO 2 in a single point in the main artery of a rat tail. Their measurements were confined to the blood volume because the G2 dye does not penetrate vessel walls due to its relatively large molecular size. 36, 37 In the work presented here, we were able to measure pO 2 in the solid tissue because MB is a small molecule that rapidly stains tissue by diffusion. In order to map the distribution of pO 2 in the solid tissue, a full two-dimensional imaging technique has been implemented.
Materials and Methods

Multimodal Imaging System
The schematic of the multimodal system is shown in Fig. 1 . The system allowed for three modes of operation: pulse-echo US imaging, PAI, and PALI. The pump laser was a pulsed Nd:YAG laser (Surelite I, Continuum), equipped with a third harmonics generation module, emitting short pulses (5 ns) at 355 nm. An optical parametric oscillator (OPO, MagicPRISM, OPOTEK, Carlsbad, CA) was used in conjunction with the laser to generate a wavelength of 650 nm to match the peak absorption of MB in its ground state. A frequency-doubled Nd:YAG pulsed laser (Brilliant, Quantel, Bozeman, MT, 532 nm, 5 ns) commercially integrated with a second OPO unit served as the probe laser. The integrated laser system (Rainbow, OPOTEK) provided a tuning range from 680 to 960 nm. The output wavelength of this laser system was tuned to 810 nm to match the excited state triplettriplet peak absorption of MB. The pulse energies at 650 and 810 nm were measured to be 8 and 10 mJ, respectively. A set of prisms was used to align the two beams such that they overlapped at the surface of the imaging object. The light intensities of the two beams were approximately 8 and 13 mJ∕cm 2 , which are below the ANSI limit. 38 Both the lasers were externally triggered by an field-programmable gate array (FPGA) module (Saxo FPGA board, KNJN, California) at a 10 Hz repetition rate. The time delay between the pump and probe pulses was controlled by a PC via a parallel port connection to the FPGA module. The module Fig. 1 Schematic of in vivo multimodal imaging system. The system was capable of generating ultrasound (US), photoacoustic imaging (PAI), and photoacoustic lifetime imaging (PALI) images using the same hardware. The animal was illuminated by two laser systems triggered by an FPGA module. Both pulse-echo US and PA signals were acquired by a conventional phased-array US transducer and then amplified, digitized, and stored in the US system. Data were transferred to a PC for image processing and display.
also triggered the signal acquisition of a 64-channel US system (OPEN system, Lecoeur Electronique, Chuelles, France). The US system was connected to a 64-element US phased-array transducer (P7-4, ATL). This transducer has 64 elements arranged in a linear array configuration with interelement spacing of 0.18 mm. The center frequency of the transducer is 5 MHz and its bandwidth is 3 MHz. The same transducer was used as a transmitter-receiver in pulse-echo US imaging mode and as a receiver-only in PAI and PALI. All the 64 channels were digitized simultaneously at 12-bit resolution. The amplification gain of each channel can be programmed from 0 to 79.9 dB. The data were stored in an internal buffer and then transferred to a PC for image reconstruction and processing. The 80-MHz internal clock of the US system was utilized as a common time-base for all other clocks and triggering signals in the multimodal imaging system, thereby ensuring minimal jitter between laser pulses and PA signal acquisition.
US Imaging
In US imaging mode, the lasers were turned off, and the US system triggering was set to internal. The US images were obtained by the synthetic transmit aperture method. 39, 40 At each step, only one channel of the phased array emitted an US pulse, and the reflected backscattering signals were simultaneously recorded on all 64 channels. This step was repeated until the echo signals from every emitting channel were acquired. The signal acquisition time for a complete scan was <100 ms. This method generates a data set from which signals corresponding to any pair of emitting and receiving elements can be extracted. For each emitting element, an amplitude image was reconstructed by the delay-and-sum method, 41 followed by Hilbert transformation along the axial direction for conversion to a complex, analytical signal. Finally, all complex amplitude images were summed, and the absolute values were presented using dB scales.
PAI and PALI
When working in PAI and PALI modes, both lasers were turned on, and the US system was then set to external triggering mode with the US pulse generator turned off to reduce electronic noise. The PA signal acquired by the US array was averaged over 100 measurements to compensate for the fluctuations in the OPO output energy. A filtered backprojection algorithm was applied to reconstruct the PA images. 42 The PA signal was filtered by a zero phase-shift finite impulse response filter with bandwidth of 3 to 7 MHz and then processed through a coherent summation procedure to generate the PA amplitude at each pixel in the field of view. Envelope detection was then applied by taking the absolute value of the Hilbert transform of the PA amplitudes along lines in the depth direction. The final step was required for generating a unipolar PA image.
A series of PA signals was obtained with pump-probe delays (τ) of 0.25 μs, 0.5 μs, 1 μs, 2 μs, 4 μs, 8 μs, and 100 ms. The delay was accomplished by changing the time of the pump with respect to the triggering signal to US system. At each delay, PA signals were recorded with the probe beam both on (synchronized with start of US signal acquisition) and off. Taking into account the 10-Hz repetition rate and the time for data transfer, the total imaging acquisition time was ∼150 s. This includes averaging of 100 samples for each PA signal. In order to extract the transient PA signal, the following steps were applied. First, the PA signal corresponding to the 810-nm laser (S 810 ) was calculated by subtracting the PA signal generated by the 650-nm laser only (S 650 ) from the PA signals generated with both lasers (650 and 810 nm) emitting (S 810þ650 ) at a specific pump-probe time delay (τ 0 ), as described by Eq. (1). S 810;τ¼τ 0 ¼ S 650þ810;τ¼τ 0 − S 650;τ¼τ 0 .
(1)
The S 810 signal had two independent components, a background absorption signal due to light absorption in tissue (mostly in hemoglobin) (S 810;background ) and a transient absorption signal of MB at τ 0 (S 810;transient;τ¼τ 0 ). The two components were separated using a background suppression method described by Huang et al. 43 in more detail below. The background absorption is independent of the pump-probe time delay. Therefore, the background PA signal was obtained by separating the two individual PA responses (650 and 810 nm) at a long τ (100 ms), a value that is much longer than the normal range of lifetime of MB (<100 μs). The transient PA signal was then obtained by subtracting the background PA signal at 810 nm from the total PA signal at 810 nm. 
Additionally, the coefficient of determination, R 2 , was computed at each pixel to reflect the goodness of fit. The amplitude threshold was set to be a quarter of the global maximum amplitude of the PA image. An amplitude above threshold and an R 2 value >0.8 were used as selection criteria to ensure the validity of lifetime estimates. Only pixels that met both criteria were converted to pO 2 values and displayed in a color scale. The Stern-Volmer relationship [Eq. (5)] describing the lifetime as a function of pO 2 44 was used to convert lifetime to pO 2 :
where T 0 is the lifetime at pO 2 ¼ 0, and k Q is the quenching rate constant. For MB; T 0 ¼ 79.5 μs, and k Q ¼ 0.0036 μs −1 mmHg −1 . 33 
Phantom Imaging
To demonstrate the capability of multimodal imaging, we tested the imaging system using a phantom consisting of two tubes. The experimental setup is shown in Fig. 2(a) and 2(b) . Two plastic tubes (inner diameter 0.7 mm and outer diameter 2.4 mm) containing MB aqueous solution at different pO 2 values were placed perpendicular to the scanning plane. The solution in each tube was in closedflow circulation with an oxygenation cell, in which the pO 2 level was controlled by gas bubbling. One cell was bubbled by air so that the pO 2 of the solution was airequilibrated, and the other one was bubbled by pure nitrogen. The US transducer was placed near the tubes, with both lasers illuminating the tubes from the side [left side of Fig. 2(a) ]. Both PA and US signals were recorded without moving the tubes and transducer. PA images at a series of time delays were reconstructed, and the lifetime was extracted and converted to pO 2 for display.
Animal Preparation
Tumor-bearing nude mice were used as a cancer model in this study. Tumors were induced by injecting LNCaP cells into the hindlimbs. The LNCaP cell line was derived from human prostate adenocarcinoma and has been commonly used in cancer research. [45] [46] [47] Specifically, 1 × 10 6 cells suspended in 0.1 mL Matrigel matrix (50% Matrigel and 50% LNCaP growth medium) were subcutaneously injected into the hindlimb of each 24-g nude mouse. Tumors grown for 3 to 5 weeks with a diameter of 5 to 10 mm were considered appropriate for further experiments. Methylene blue (MB hydrate, Fluka, Sigma-Aldrich, St. Louis, MO) was dissolved in physiological saline (DPBS 1×, Mediatech, Manassas, VA) to a concentration of 5 mM. After the animal was anesthetized by ketamine (100 mg∕kg) and xylazine (10 mg/kg), the MB solution was injected into the hindlimb. The amount of MB injection was 0.2 to 0.6 mL at each spot (5 to 10 mm between injection spots, total injection volume was limited to 1 mL for a given hindlimb). Data acquisition was initiated after 10 to 15 min to allow the dye to sufficiently diffuse in the tissue. All animal procedures and care were performed according to protocols approved by the University of Minnesota Institutional Animal Care and Use Committee in accordance with federally approved guidelines.
In Vivo Oxygen Imaging and Measurement
The animals were divided into two groups: mice with hindlimb tumor (group A, n A ¼ 8) and control non-tumor-bearing mice (group B, n B ¼ 10). Two animals from each group were randomly chosen for imaging, whereas the rest were used for direct measurements using an oxygen probe for comparison. In group A, both the PALI and oxygen probe were applied to quantify the pO 2 of the tumor and normal tissue at the hindlimbs. In group B, pO 2 of the non-tumor-bearing hindlimb of control mice were measured by both methods. The pO 2 values in PALI were obtained from individual pixel values within regions of interest in the images, whereas the pO 2 values by the oxygen probe were directly recorded. The statistics of pO 2 values obtained by PALI and the probe with three types of tissues (tumor tissue, normal tissue, and control mice) were compared.
The animal chosen for imaging was transferred to the imaging platform as shown in Fig. 3 . The imaging platform included an animal holder in order to keep the hindlimb of the animal submerged in water and the head above the surface for normal breathing. The transducer and platform were fixed by mechanical arms so that the relative position of the animal and US transducer did not change throughout the experiment. The water temperature was kept at 35°C AE 0.5°C by a digital heating system (T3-150, Transworld Aquatic Enterprises, Inglewood, CA). The US images were generated to provide the anatomical structure of the hindlimb. PA images at each pump-probe delay were obtained and then processed to yield the PALI image. After the imaging procedures, the animal was euthanized.
To perform direct oxygen measurements, the animal was first anesthetized and transferred to a heater pad. The pO 2 of the hindlimb was then assessed by a commercial single-point oxygen probe. The device consists of a retractable needle-type oxygen sensor (sensor tip diameter 50 μm, surrounded by a 40-mm-long and 0.8-mm-wide syringe needle, OXR50, Pyroscience, Aachen, Germany) and optical oxygen meter (Firesting O 2 , Pyroscience). The Firesting O 2 system is a PC-controlled fiber-optic oxygen meter that measures pO 2 by quantifying the oxygen-dependent phosphorescence of a dye-stained polymer membrane located at the tip of the optical fiber. The oxygen sensor was inserted into tissue with the needle. By pulling out the probe in a step-wise manner, pO 2 values along the needle path at different depths were recorded. Typically, three needle penetrations were made in one hindlimb and two to four stable 
Results
Phantom Imaging
An example of multimodal imaging results of a phantom is given in Fig. 2(c) and 2(d) . Figure 2(c) shows the PA image of the phantom. Figure 2(d) shows the superposition of the PALI image onto the US image. Both the PA and US images correctly reflect the structure of the phantom, with the PA image showing the optical absorption of the contents inside the tubes and the US image indicating the inner and outer walls. The different levels of pO 2 in the two tubes are shown in the PALI image. The pO 2 within the left and right tubes were set to 50 and 150 mmHg, respectively. The PALI image clearly shows the levels in the range of 40 to 60 mmHg and 130 to 160 mmHg for the left and right tubes, respectively.
In Vivo Imaging
The setup for the in vivo measurements is shown in Fig. 3 . PA and PALI images were superposed onto the US image. As can be seen from Fig. 3 , the laser beams illuminated only a portion of the hindlimb due to the limited power of the lasers. Therefore, both PA and PALI images covered less area than the US image [ Fig. 4(a) ]. The PA image shows the amplitude distribution resulting from the background absorption [ Fig. 4(b) ] and MB's transient absorption [ Fig. 4(c) ]. The transient PA amplitudes associated with two pixels, along with their exponential decay determined by curvefitting, are shown in Fig. 4(e) . The two pixels correspond to points with high and low pO 2 . The hypoxic region imaged by PALI [ Fig. 4(d) ] is consistent with the site of the tumor imaged by US. We have also applied the same technique to the control mice without tumor. The PALI images indicate inhomogeneous tissue oxygenation within the normal muscle tissue, and the pO 2 values were within the normal physiological range.
Correlative In Vivo Measurement
We have performed correlative direct measurements using the oxygen needle sensor in tumor-bearing mice and control mice. The total number of valid pO 2 readings for tumor tissue, normal tissue of tumor-bearing mice, and control mice was 38, 39, and 121, respectively. The three groups of measurements were then compared with the pO 2 values extracted from PALI images. The frequency distributions of the pO 2 values are displayed in a histogram shown in Fig. 5(a) . The three regions for statistical analysis of pO 2 distribution via PALI are labeled in Fig. 5(b) and 5(c) . We performed two-sample t-tests. The results show a statistically significant difference in pO 2 distribution between tumors and other tissues, with p values <0.05 by both PALI and the needle probe. Both PALI and direct oxygen measurements confirmed that the tissue oxygen level in the tumors is significantly lower (∼20mmHg) than that in normal tissue and control mice.
Discussion
Tissue pO 2 is a key regulator of physiological function, and changes in tissue oxygenation play a critical role in the pathophysiology of a wide range of diseases. In cancer, particularly, low pO 2 in tumors indicates poor prognosis and low efficacy of radiotherapy and chemotherapy. Imaging of pO 2 can significantly improve the quality of diagnosis and treatment planning for cancer patients. Nevertheless, current imaging modalities fail to provide a suitable clinical solution.
In this work, we have demonstrated the in vivo application of PALI for tissue oxygen imaging in small animals. PALI is a novel and alternative method for in vivo oxygen imaging with the advantages of rapid image acquisition, involving nonionizing laser radiation and using a nonradioactive optical contrast agent. In this work, we used MB, a dye that has been widely used in therapeutic and diagnostic applications. The imaging results confirm the existence of hypoxic area caused by the solid tumor. The statistical distribution of pO 2 was compared to direct measurements by an optical needle sensor system. An overall shift toward higher pO 2 values in PALI compared to direct measurements was found. This may have resulted from the higher body temperature during PALI imaging (water temperature of 35°C) versus needle sensor measurements (room temperature of 22°C), which might affect blood circulation and tissue oxygenation.
To achieve these measurements, a multimodal (US imaging, PAI, PALI) imaging system has been developed. All three imaging modes share the same US transducer, thereby eliminating the need for image coregistration of anatomical and functional informations. The system employs a commercial 64-element phased-array US transducer. It is optimally designed for clinical US imaging in applications such as echocardiography where limited aperture is required.
The limitations imposed by the limited bandwidth and aperture size compromise accurate reconstruction of largescale structures. The problem of implementing PAI using US imaging arrays has been investigated by several groups. [48] [49] [50] These studies show that PA images can still adequately represent tissue structure and morphology by relying on differences in small-scale structure of different tissue types and on the high visibility of interfaces causing abrupt gradients in optical absorption.
The phantom imaging results demonstrate that the system was able to achieve pO 2 distribution of submillimeter structures. Based on the resulting in vivo PALI images, the maximal imaging depth of the system is estimated to be ∼12 mm. The imaging depth is expected to be improved by increasing the laser energy density. The images also show lack of continuity in the field of view. The regions of valid PALI data consist of isolated "islands" in the field of view. This is mostly a result of low intensity of the excitation laser pulse resulting in low excitation efficiency. This limitation is primarily due to the finite penetration depth of the excitation light in tissue.
One of the advantages of sensing oxygen via PA lifetime is its robustness to large variations in the concentration of the oxygen-sensitive dye and in the intensity of the light. However, low concentrations of the dye and inadequate fluence rate both contribute to a reduction in signal-to-noise ratio, making oxygen measurement less accurate. An additional source of noise is attributed to the fluctuations in the pulse energy of both the pump and probe laser. A set of criteria has been developed and implemented to validate the oxygen information. These criteria include a high PA amplitude level and a high R 2 value for exponential fit used for evaluating lifetime.
The results presented indicate that PALI can be used for mapping tissue oxygen in vivo. Furthermore, the work demonstrates the technical capability of multimodality imaging (US, PAI, and PALI) and its usefulness in visualizing functional imaging data. The technique is very attractive for a range of clinical applications in which tissue oxygen mapping would improve therapy decision making and treatment planning. Examples include cancer treatments (radiotherapy and PDT) and treatments of diabetes-related ulcers. A more comprehensive validation study of PALI is still required before its implementation in clinical applications could be established. In addition, other methods of light delivery, such as the use of minimallyinvasive, tissue-penetrating fiber diffusers, should be explored in order to extend the applicability of PALI into an even broader range of clinical applications. 
